How did Israel’s strike on Iran impact oil prices?
Why are US stock futures falling after Middle East attacks?
What caused the drop in Tesla's stock today?
How will Meta’s investment in Scale AI affect AI development?
Why is JPMorgan warning about $120 oil prices?
What led to JBS’s NYSE debut and investor concerns?
How are tariffs affecting innovation at small businesses?
BioNTech Expands mRNA Cancer Portfolio With CureVac $1.25 Billion All-Stock Deal
benzinga.com/m-a/25/06/45907865/biontech-mrna-cancer-portfolio-curevac-all-stock-deal
BioNTech SE (NASDAQ:BNTX) on Thursday agreed to acquire CureVac N.V. (NASDAQ:CVAC) in an all-stock transaction.
According to the agreement, shareholders can exchange CureVac shares for around $5.46 in BioNTech ADSs. This equates, roughly, to an equity value of $1.25 billion.
The…
This story appeared on benzinga.com, 2025-06-12 15:07:51.